JP Morgan Chase
TARA icon

JP Morgan Chase’s Protara Therapeutics TARA Stock Holding History

JP Morgan Chase’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Buy
21,490
+6,906
+47% +$40.9K ﹤0.01% 5806
2025
Q4 		$77.7K Buy
14,584
+247
+2% +$1.37K ﹤0.01% 6018
2025
Q3 		$62.4K Sell
14,337
-927
-6% -$3K ﹤0.01% 6146
2025
Q2 		$46.3K Buy
+15,264
New +$52.7K ﹤0.01% 5956
2024
Q2 		– Sell
-22
Closed -$88 – 7736
2024
Q1 		$88 Buy
22
+6
+38% +$19 ﹤0.01% 6928
2023
Q4 		$30 Buy
16
+5
+45% +$7 ﹤0.01% 7283
2023
Q3 		$18 Buy
+11
New +$25 ﹤0.01% 7197
2022
Q3 		– Sell
-352
Closed -$1K – 6846
2022
Q2 		$1K Buy
+352
New +$1.29K ﹤0.01% 6383
2022
Q1 		– Sell
-1,103
Closed -$7K – 7005
2021
Q4 		$7K Sell
1,103
-6,937
-86% -$47.8K ﹤0.01% 6385
2021
Q3 		$56K Buy
8,040
+7,863
+4,442% +$61.3K ﹤0.01% 5803
2021
Q2 		$2K Sell
177
-1,376
-89% -$15.6K ﹤0.01% 6214
2021
Q1 		$24K Sell
1,553
-160
-9% -$2.97K ﹤0.01% 5677
2020
Q4 		$41K Buy
1,713
+198
+13% +$4.27K ﹤0.01% 5202
2020
Q3 		$26K Sell
1,515
-29
-2% -$672 ﹤0.01% 5102
2020
Q2 		$45K Buy
1,544
+1,292
+513% +$40K ﹤0.01% 4858
2020
Q1 		$6K Buy
+252
New +$7.34K ﹤0.01% 5106

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

JP Morgan Chase's TARA Position: Q1 2026 in Review

JP Morgan Chase increased its Protara Therapeutics (TARA) stake by 47% in Q1 2026, buying an estimated $40.9K and bringing the position to 21,490 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #5806.

JP Morgan Chase first reported a position in TARA in Q1 2020 and has held it in 16 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • JP Morgan Chase held 21,490 shares of Protara Therapeutics worth $104K as of Q1 2026.
  • JP Morgan Chase bought 6,906 Protara Therapeutics shares in Q1 2026, an estimated $40.9K.
  • Protara Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5806 holding.
  • JP Morgan Chase first reported a position in Protara Therapeutics in Q1 2020 and has held it in 16 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.